Involvement of the opportunistic pathogen Aspergillus tubingensis in osteomyelitis of the maxillary bone: A case report

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Bathoorn, Erik ^a,b   Escobar Salazar, Natalia ^b   Sepehrkhouy, Shahrzad ^a   Meijer, Martin ^c   de Cock, Hans ^b   Haas, Pieter Jan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

Author keywords

Aspergillus section nigri; Aspergillus tubingensis; Invasive mould infection; Species identification

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; CYCLOSPORIN; FLUCONAZOLE; FLUCYTOSINE; IMIPENEM; ITRACONAZOLE; MYCOPHENOLIC ACID; POSACONAZOLE; PREDNISONE; PYRROLE DERIVATIVE; VORICONAZOLE;

ADULT; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS TUBINGENSIS; BIOPSY; CASE REPORT; CONNECTIVE TISSUE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLAMMATION; MALE; MAXILLA; MINIMUM INHIBITORY CONCENTRATION; NUCLEOTIDE SEQUENCE; OPPORTUNISTIC INFECTION; OSTEOMYELITIS; PARANASAL SINUSITIS; SPECIES IDENTIFICATION; TISSUE CULTURE; TOOTH EXTRACTION; WOUND;

ASPERGILLOSIS; ASPERGILLUS; HUMANS; MALE; MAXILLA; OPPORTUNISTIC INFECTIONS; OSTEOMYELITIS; PHYLOGENY; TUBULIN; YOUNG ADULT;

EID: 84873041357     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-59     Document Type: Article

References (18)

1. Mosseray R. Les aspergillus de la section " Niger" Thom et Church. La Cellule Journal 1934, 43:203-285.
2. Perrone G, Varga J, Susca A, Frisvad JC, Stea G, Kocsube S, et al. Aspergillus uvarum sp. nov., an uniseriate black Aspergillus species isolated from grapes in Europe. Int J Syst Evol Microbiol 2008, 58:1032-1039. 10.1099/ijs.0.65463-0, 18398215.
3. Samson RA, Noonim P, Meijer M, Houbraken J, Frisvad JC, Varga J. Diagnostic tools to identify black aspergilli. Stud Mycol 2007, 59:129-145. 10.3114/sim.2007.59.13, 2275192, 18490945.
4. Perrone G, Stea G, Epifani F, Varga J, Frisvad JC, Samson RA. Aspergillus niger contains the cryptic phylogenetic species A. awamori. Fungal Biol 2011, 115:1138-1150. 10.1016/j.funbio.2011.07.008, 22036292.
5. Samson RA, Varga J. What is a species in Aspergillus?. Med Mycol 2009, 47(Suppl 1):S13-S20.
6. Meijer M, Houbraken JA, Dalhuijsen S, Samson RA, de Vries RP. Growth and hydrolase profiles can be used as characteristics to distinguish Aspergillus niger and other black aspergilli. Stud Mycol 2011, 69:19-30. 10.3114/sim.2011.69.02, 3161755, 21892240.
7. Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin Microbiol Infect 2008, 14:982-984. Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing.
8. Munguia R, Daniel SJ. Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol 2008, 72:453-459. 10.1016/j.ijporl.2007.12.005, 18279975.
9. Winslow CP, Dichard A, McGuire KA. Osteomyelitis of the temporomandibular joint. Am J Otolaryngol 2001, 22:142-145. 10.1053/ajot.2001.22577, 11283831.
10. Abrahams JJ, Berger SB. Oral-maxillary sinus fistula (oroantral fistula): clinical features and findings on multiplanar CT. AJR Am J Roentgenol 1995, 165:1273-1276.
11. Szigeti G, Sedaghati E, Mahmoudabadi AZ, Naseri A, Kocsube S, Vagvolgyi C, et al. Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran. Mycoses 2012, 55:333-338. 10.1111/j.1439-0507.2011.02103.x, 21895787.
12. Arabatzis M, Kambouris M, Kyprianou M, Chrysaki A, Foustoukou M, Kanellopoulou M, et al. Polyphasic identification and susceptibility to seven antifungals of 102 Aspergillus isolates recovered from immunocompromised hosts in Greece. Antimicrob Agents Chemother 2011, 55:3025-3030. 10.1128/AAC.01491-10, 3101447, 21444701.
13. Szigeti G, Kocsube S, Doczi I, Bereczki L, Vagvolgyi C, Varga J. Molecular identification and antifungal susceptibilities of black Aspergillus isolates from otomycosis cases in Hungary. Mycopathologia 2012, 174(2):143-147. 10.1007/s11046-012-9529-8, 22359155.
14. Hendrickx M, Beguin H, Detandt M. Genetic re-identification and antifungal susceptibility testing of Aspergillus section Nigri strains of the BCCM/IHEM collection. Mycoses 2012, 55:148-155.
15. Balajee SA, Kano R, Baddley JW, Moser SA, Marr KA, Alexander BD, et al. Molecular identification of Aspergillus species collected for the transplant-associated infection surveillance network. J Clin Microbiol 2009, 47:3138-3141. 10.1128/JCM.01070-09, 2756904, 19675215.
16. Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Cuenca-Estrella M, Rodriguez-Tudela JL. Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri. Antimicrob Agents Chemother 2009, 53:4514-4517. 10.1128/AAC.00585-09, 2764190, 19635955.
17. Howard SJ, Harrison E, Bowyer P, Varga J, Denning DW. Cryptic species and azole resistance in the Aspergillus niger complex. Antimicrob Agents Chemother 2011, 55:4802-4809. 10.1128/AAC.00304-11, 3186969, 21768508.
18. Meletiadis J, Mavridou E, Melchers WJ, Mouton JW, Verweij PE. Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis. Antimicrob Agents Chemother 2012, 56(5):2524-2529. 10.1128/AAC.05959-11, 3346643, 22330922.